CN104857089B - 一种治疗风湿和类风湿性关节炎的药液及其制备方法 - Google Patents
一种治疗风湿和类风湿性关节炎的药液及其制备方法 Download PDFInfo
- Publication number
- CN104857089B CN104857089B CN201510262274.2A CN201510262274A CN104857089B CN 104857089 B CN104857089 B CN 104857089B CN 201510262274 A CN201510262274 A CN 201510262274A CN 104857089 B CN104857089 B CN 104857089B
- Authority
- CN
- China
- Prior art keywords
- grams
- decoction
- rheumatoid arthritis
- mouse
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241001526348 Myospalax Species 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- 244000153955 Reynoutria sachalinensis Species 0.000 claims abstract description 15
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims abstract description 15
- 241000133134 Saussurea Species 0.000 claims abstract description 14
- 235000012907 honey Nutrition 0.000 claims abstract description 13
- 238000011282 treatment Methods 0.000 claims description 26
- 238000000034 method Methods 0.000 abstract description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 19
- 201000010099 disease Diseases 0.000 abstract description 17
- 206010012335 Dependence Diseases 0.000 abstract description 11
- 210000000988 bone and bone Anatomy 0.000 abstract description 11
- 210000003205 muscle Anatomy 0.000 abstract description 7
- 231100000862 numbness Toxicity 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 7
- 230000036592 analgesia Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 5
- 206010067484 Adverse reaction Diseases 0.000 abstract description 4
- 230000006838 adverse reaction Effects 0.000 abstract description 4
- 230000009545 invasion Effects 0.000 abstract description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 41
- 239000003814 drug Substances 0.000 description 38
- 239000007788 liquid Substances 0.000 description 26
- 230000000694 effects Effects 0.000 description 25
- 208000002193 Pain Diseases 0.000 description 19
- 239000008280 blood Substances 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 17
- 239000002504 physiological saline solution Substances 0.000 description 17
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 12
- 230000006872 improvement Effects 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 229960001138 acetylsalicylic acid Drugs 0.000 description 11
- 238000011160 research Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 108010074051 C-Reactive Protein Proteins 0.000 description 8
- 102100032752 C-reactive protein Human genes 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 241001145025 Saussurea involucrata Species 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010023232 Joint swelling Diseases 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 201000004595 synovitis Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 230000000146 antalgic effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 210000001188 articular cartilage Anatomy 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000002562 urinalysis Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- MHUPGVCFEGYWMI-QQOHENMQSA-N (3r,3ar,4r,6ar,9ar,9br)-4-hydroxy-3-methyl-6,9-dimethylidene-3a,4,5,6a,7,8,9a,9b-octahydro-3h-azuleno[4,5-b]furan-2-one Chemical compound [C@@H]1([C@@H](CC(=C)[C@H]2[C@@H]3C(CC2)=C)O)[C@@H]3OC(=O)[C@@H]1C MHUPGVCFEGYWMI-QQOHENMQSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010051728 Bone erosion Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000398985 Cricetidae Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000026214 Skeletal muscle atrophy Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- MHUPGVCFEGYWMI-UHFFFAOYSA-N Xuelianlactone Natural products C1CC(=C)C2C1C(=C)CC(O)C1C2OC(=O)C1C MHUPGVCFEGYWMI-UHFFFAOYSA-N 0.000 description 1
- 239000009395 Zhengqing Fengtongning Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000025185 skeletal muscle atrophy Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 238000009923 sugaring Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510262274.2A CN104857089B (zh) | 2015-05-21 | 2015-05-21 | 一种治疗风湿和类风湿性关节炎的药液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510262274.2A CN104857089B (zh) | 2015-05-21 | 2015-05-21 | 一种治疗风湿和类风湿性关节炎的药液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104857089A CN104857089A (zh) | 2015-08-26 |
CN104857089B true CN104857089B (zh) | 2018-04-06 |
Family
ID=53903556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510262274.2A Expired - Fee Related CN104857089B (zh) | 2015-05-21 | 2015-05-21 | 一种治疗风湿和类风湿性关节炎的药液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104857089B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109010445A (zh) * | 2018-08-23 | 2018-12-18 | 上海交通大学医学院附属新华医院 | 一种针对慢性阻塞性肺病患者呼吸道定植菌的中药复方 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301544A (zh) * | 1999-12-30 | 2001-07-04 | 中国科学院西北高原生物研究所 | 治疗关节炎及骨关节病的药物组合物及其制备方法 |
-
2015
- 2015-05-21 CN CN201510262274.2A patent/CN104857089B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1301544A (zh) * | 1999-12-30 | 2001-07-04 | 中国科学院西北高原生物研究所 | 治疗关节炎及骨关节病的药物组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
中药虎杖的药理研究进展;樊慧婷等;《中国中药杂志》;20130831;第38卷(第15期);第2545-2548页 * |
黄芪提取物抗炎、镇痛、耐缺氧及抗疲劳作用的研究;朱华野等;《时珍国医国药》;20071231;第18卷(第5期);第1156-1157页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104857089A (zh) | 2015-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102441081A (zh) | 一种治疗痛风病的药物及其制备方法 | |
CN109602794A (zh) | 一种治疗骨关节炎的中药组合物及制备方法和用途 | |
CN102626449A (zh) | 一种治疗中风偏瘫的胶囊 | |
CN101912536B (zh) | 一种治疗风湿类风湿的药物组合物 | |
CN104857089B (zh) | 一种治疗风湿和类风湿性关节炎的药液及其制备方法 | |
CN102240351B (zh) | 一种治疗关节炎骨质增生椎间盘突出颈椎病的中药药物 | |
CN102430015A (zh) | 一种治疗肾炎及尿毒症的中药制剂及其制备方法 | |
CN106215046A (zh) | 一种治疗急性痛风性关节炎的中药 | |
CN106039109A (zh) | 防治寒湿阻络型的类风湿性关节炎的中药药酒 | |
CN101518631B (zh) | 治疗类风湿关节炎用药物 | |
CN104548049A (zh) | 一种治疗老年性骨质疏松症的中药组合物及其制备方法 | |
CN100427132C (zh) | 一种治疗痹症的中药及其制备方法 | |
CN102274336B (zh) | 一种治疗类风湿性关节炎的药物组合物 | |
CN104225387A (zh) | 一种治疗湿热阻滞型糖尿病足的中药组合物 | |
CN103550620B (zh) | 一种治疗风湿疼痛的外用药物组合物 | |
CN103751703A (zh) | 一种治疗痹症的中药药酒及其制备方法 | |
CN103239503A (zh) | 一种治疗骨痛病的中药制剂及其制备方法 | |
CN103157072B (zh) | 一种用于治疗颈椎病的中药组合物 | |
CN102755487A (zh) | 祛湿活血中药粉 | |
CN102430057B (zh) | 一种治疗风湿疼痛的药物组合物 | |
CN105434986A (zh) | 用于治疗关节痛的中药制剂 | |
CN105012709B (zh) | 用于痿症的补肾温阳丸 | |
CN118320028A (zh) | 中药组合物、制备方法及应用 | |
CN109481553A (zh) | 通痹舒筋丸 | |
CN103330843B (zh) | 治疗产后风湿的药酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151028 Address after: 461670, eastern section of Binhe Road, Xuchang, Henan, Yuzhou Applicant after: XUCHANG TIANYUAN BIOLOGICAL TECHNOLOGY CO., LTD. Address before: 461670, No. 1, Huzhu Road, West Industrial Park, Xuchang, Henan, Yuzhou Applicant before: Henan Heima Animal Medicine Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180704 Address after: 461670 Henan Yuzhou Xuchang East Industrial Agglomeration Area Medical Health Industry Park Patentee after: YUZHOU TIANYUAN BIOTECHNOLOGY CO., LTD. Address before: 461670 east section of Binhe Avenue, Yuzhou City, Xuchang, Henan Patentee before: XUCHANG TIANYUAN BIOLOGICAL TECHNOLOGY CO., LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180406 Termination date: 20210521 |